nodes	percent_of_prediction	percent_of_DWPC	metapath
Isradipine—CACNA1S—pes—melanoma	0.0934	0.561	CbGeAlD
Isradipine—CYP3A4—Temozolomide—melanoma	0.0555	0.576	CbGbCtD
Isradipine—CYP3A4—Vemurafenib—melanoma	0.0304	0.316	CbGbCtD
Isradipine—CACNA1D—ear—melanoma	0.0216	0.13	CbGeAlD
Isradipine—CACNA2D2—neck—melanoma	0.0114	0.0685	CbGeAlD
Isradipine—CYP3A4—Docetaxel—melanoma	0.0104	0.108	CbGbCtD
Isradipine—CACNB2—retina—melanoma	0.00644	0.0387	CbGeAlD
Isradipine—CACNA2D2—head—melanoma	0.00481	0.0289	CbGeAlD
Isradipine—CACNB2—head—melanoma	0.00369	0.0222	CbGeAlD
Isradipine—CACNA2D1—head—melanoma	0.00346	0.0208	CbGeAlD
Isradipine—CACNA2D2—lymph node—melanoma	0.00337	0.0203	CbGeAlD
Isradipine—Connective tissue disorder—Vemurafenib—melanoma	0.00324	0.00851	CcSEcCtD
Isradipine—CACNA1D—head—melanoma	0.00322	0.0194	CbGeAlD
Isradipine—Gynaecomastia—Carmustine—melanoma	0.00311	0.00816	CcSEcCtD
Isradipine—Throat sore—Docetaxel—melanoma	0.0031	0.00814	CcSEcCtD
Isradipine—Eye disorder—Vemurafenib—melanoma	0.00308	0.0081	CcSEcCtD
Isradipine—Oropharyngeal discomfort—Docetaxel—melanoma	0.00307	0.00806	CcSEcCtD
Isradipine—Cardiac disorder—Vemurafenib—melanoma	0.00306	0.00804	CcSEcCtD
Isradipine—Dermatitis atopic—Docetaxel—melanoma	0.00301	0.00792	CcSEcCtD
Isradipine—Angiopathy—Vemurafenib—melanoma	0.00299	0.00786	CcSEcCtD
Isradipine—CACNA1C—head—melanoma	0.00298	0.0179	CbGeAlD
Isradipine—Mediastinal disorder—Vemurafenib—melanoma	0.00297	0.00781	CcSEcCtD
Isradipine—Cerebrovascular accident—Bleomycin—melanoma	0.00295	0.00774	CcSEcCtD
Isradipine—Malnutrition—Vemurafenib—melanoma	0.00287	0.00754	CcSEcCtD
Isradipine—Back pain—Vemurafenib—melanoma	0.00278	0.0073	CcSEcCtD
Isradipine—Lethargy—Dactinomycin—melanoma	0.00275	0.00722	CcSEcCtD
Isradipine—CACNA1H—lymph node—melanoma	0.00273	0.0164	CbGeAlD
Isradipine—CACNB2—lymph node—melanoma	0.00258	0.0155	CbGeAlD
Isradipine—Cough—Vemurafenib—melanoma	0.0025	0.00658	CcSEcCtD
Isradipine—Liver function test abnormal—Dactinomycin—melanoma	0.00249	0.00653	CcSEcCtD
Isradipine—Oropharyngeal pain—Docetaxel—melanoma	0.00245	0.00645	CcSEcCtD
Isradipine—Arthralgia—Vemurafenib—melanoma	0.00244	0.00642	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00243	0.00638	CcSEcCtD
Isradipine—CACNA2D1—lymph node—melanoma	0.00242	0.0146	CbGeAlD
Isradipine—Anaphylactic shock—Vemurafenib—melanoma	0.00234	0.00616	CcSEcCtD
Isradipine—Liver function test abnormal—Carmustine—melanoma	0.00233	0.00612	CcSEcCtD
Isradipine—Nervous system disorder—Vemurafenib—melanoma	0.0023	0.00604	CcSEcCtD
Isradipine—Skin disorder—Vemurafenib—melanoma	0.00227	0.00598	CcSEcCtD
Isradipine—CACNA1D—lymph node—melanoma	0.00226	0.0136	CbGeAlD
Isradipine—Breast disorder—Temozolomide—melanoma	0.0022	0.00578	CcSEcCtD
Isradipine—Acute coronary syndrome—Bleomycin—melanoma	0.00219	0.00576	CcSEcCtD
Isradipine—Hypotension—Vemurafenib—melanoma	0.00219	0.00575	CcSEcCtD
Isradipine—Myocardial infarction—Bleomycin—melanoma	0.00218	0.00573	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00213	0.00561	CcSEcCtD
Isradipine—Fluid retention—Docetaxel—melanoma	0.00212	0.00557	CcSEcCtD
Isradipine—CACNA1C—lymph node—melanoma	0.00208	0.0125	CbGeAlD
Isradipine—Decreased appetite—Vemurafenib—melanoma	0.00204	0.00535	CcSEcCtD
Isradipine—Gastrointestinal disorder—Vemurafenib—melanoma	0.00202	0.00531	CcSEcCtD
Isradipine—Fatigue—Vemurafenib—melanoma	0.00202	0.00531	CcSEcCtD
Isradipine—Constipation—Vemurafenib—melanoma	0.002	0.00526	CcSEcCtD
Isradipine—Hypoaesthesia—Bleomycin—melanoma	0.00199	0.00522	CcSEcCtD
Isradipine—Pollakiuria—Temozolomide—melanoma	0.00194	0.00511	CcSEcCtD
Isradipine—Erectile dysfunction—Temozolomide—melanoma	0.00194	0.0051	CcSEcCtD
Isradipine—Depression—Carmustine—melanoma	0.00194	0.00509	CcSEcCtD
Isradipine—Photosensitivity reaction—Temozolomide—melanoma	0.00192	0.00505	CcSEcCtD
Isradipine—Weight increased—Temozolomide—melanoma	0.00192	0.00503	CcSEcCtD
Isradipine—Depression—Temozolomide—melanoma	0.00187	0.00492	CcSEcCtD
Isradipine—Hepatitis—Dactinomycin—melanoma	0.00186	0.0049	CcSEcCtD
Isradipine—Flushing—Bleomycin—melanoma	0.00185	0.00487	CcSEcCtD
Isradipine—Hepatobiliary disease—Temozolomide—melanoma	0.00177	0.00467	CcSEcCtD
Isradipine—Hypoaesthesia—Carmustine—melanoma	0.00173	0.00456	CcSEcCtD
Isradipine—Flushing—Dactinomycin—melanoma	0.00173	0.00454	CcSEcCtD
Isradipine—Oedema peripheral—Carmustine—melanoma	0.00172	0.00451	CcSEcCtD
Isradipine—Connective tissue disorder—Carmustine—melanoma	0.00171	0.0045	CcSEcCtD
Isradipine—Visual disturbance—Docetaxel—melanoma	0.00171	0.00449	CcSEcCtD
Isradipine—Atrial fibrillation—Docetaxel—melanoma	0.00171	0.00449	CcSEcCtD
Isradipine—Hepatitis—Temozolomide—melanoma	0.00168	0.00443	CcSEcCtD
Isradipine—Asthenia—Vemurafenib—melanoma	0.00168	0.00442	CcSEcCtD
Isradipine—Visual impairment—Carmustine—melanoma	0.00168	0.00442	CcSEcCtD
Isradipine—Hypoaesthesia—Temozolomide—melanoma	0.00168	0.00441	CcSEcCtD
Isradipine—Urinary tract disorder—Temozolomide—melanoma	0.00166	0.00437	CcSEcCtD
Isradipine—Oedema peripheral—Temozolomide—melanoma	0.00166	0.00436	CcSEcCtD
Isradipine—Cardiac failure—Docetaxel—melanoma	0.00166	0.00436	CcSEcCtD
Isradipine—Pruritus—Vemurafenib—melanoma	0.00166	0.00436	CcSEcCtD
Isradipine—Connective tissue disorder—Temozolomide—melanoma	0.00166	0.00435	CcSEcCtD
Isradipine—Lethargy—Docetaxel—melanoma	0.00165	0.00434	CcSEcCtD
Isradipine—Urethral disorder—Temozolomide—melanoma	0.00165	0.00434	CcSEcCtD
Isradipine—Eye disorder—Carmustine—melanoma	0.00163	0.00428	CcSEcCtD
Isradipine—Visual impairment—Temozolomide—melanoma	0.00162	0.00427	CcSEcCtD
Isradipine—Pain in extremity—Docetaxel—melanoma	0.00162	0.00426	CcSEcCtD
Isradipine—Flushing—Carmustine—melanoma	0.00162	0.00425	CcSEcCtD
Isradipine—Ill-defined disorder—Bleomycin—melanoma	0.00161	0.00424	CcSEcCtD
Isradipine—Anaemia—Bleomycin—melanoma	0.00161	0.00422	CcSEcCtD
Isradipine—Diarrhoea—Vemurafenib—melanoma	0.0016	0.00421	CcSEcCtD
Isradipine—Eye disorder—Temozolomide—melanoma	0.00157	0.00414	CcSEcCtD
Isradipine—Malaise—Bleomycin—melanoma	0.00157	0.00412	CcSEcCtD
Isradipine—Cardiac disorder—Temozolomide—melanoma	0.00156	0.00411	CcSEcCtD
Isradipine—Flushing—Temozolomide—melanoma	0.00156	0.00411	CcSEcCtD
Isradipine—Leukopenia—Bleomycin—melanoma	0.00156	0.00409	CcSEcCtD
Isradipine—Dizziness—Vemurafenib—melanoma	0.00155	0.00407	CcSEcCtD
Isradipine—Angiopathy—Temozolomide—melanoma	0.00153	0.00402	CcSEcCtD
Isradipine—Mental disorder—Carmustine—melanoma	0.00153	0.00401	CcSEcCtD
Isradipine—Immune system disorder—Temozolomide—melanoma	0.00152	0.004	CcSEcCtD
Isradipine—Mediastinal disorder—Temozolomide—melanoma	0.00152	0.00399	CcSEcCtD
Isradipine—Malnutrition—Carmustine—melanoma	0.00152	0.00399	CcSEcCtD
Isradipine—Cough—Bleomycin—melanoma	0.00152	0.00399	CcSEcCtD
Isradipine—Ill-defined disorder—Dactinomycin—melanoma	0.0015	0.00395	CcSEcCtD
Isradipine—Anaemia—Dactinomycin—melanoma	0.0015	0.00394	CcSEcCtD
Isradipine—Liver function test abnormal—Docetaxel—melanoma	0.0015	0.00393	CcSEcCtD
Isradipine—Vomiting—Vemurafenib—melanoma	0.00149	0.00391	CcSEcCtD
Isradipine—Chest pain—Bleomycin—melanoma	0.00148	0.00389	CcSEcCtD
Isradipine—Rash—Vemurafenib—melanoma	0.00148	0.00388	CcSEcCtD
Isradipine—Mental disorder—Temozolomide—melanoma	0.00148	0.00388	CcSEcCtD
Isradipine—Dermatitis—Vemurafenib—melanoma	0.00148	0.00388	CcSEcCtD
Isradipine—Back pain—Carmustine—melanoma	0.00147	0.00386	CcSEcCtD
Isradipine—Headache—Vemurafenib—melanoma	0.00147	0.00386	CcSEcCtD
Isradipine—Malnutrition—Temozolomide—melanoma	0.00147	0.00385	CcSEcCtD
Isradipine—Breast disorder—Docetaxel—melanoma	0.00146	0.00385	CcSEcCtD
Isradipine—Discomfort—Bleomycin—melanoma	0.00146	0.00384	CcSEcCtD
Isradipine—Malaise—Dactinomycin—melanoma	0.00146	0.00384	CcSEcCtD
Isradipine—Cramp muscle—Docetaxel—melanoma	0.00146	0.00383	CcSEcCtD
Isradipine—Leukopenia—Dactinomycin—melanoma	0.00145	0.00381	CcSEcCtD
Isradipine—Vision blurred—Carmustine—melanoma	0.00143	0.00376	CcSEcCtD
Isradipine—Oedema—Bleomycin—melanoma	0.00142	0.00373	CcSEcCtD
Isradipine—Anaphylactic shock—Bleomycin—melanoma	0.00142	0.00373	CcSEcCtD
Isradipine—Back pain—Temozolomide—melanoma	0.00142	0.00373	CcSEcCtD
Isradipine—Anaemia—Carmustine—melanoma	0.0014	0.00369	CcSEcCtD
Isradipine—Nausea—Vemurafenib—melanoma	0.00139	0.00366	CcSEcCtD
Isradipine—Thrombocytopenia—Bleomycin—melanoma	0.00139	0.00365	CcSEcCtD
Isradipine—Vision blurred—Temozolomide—melanoma	0.00138	0.00363	CcSEcCtD
Isradipine—Discomfort—Dactinomycin—melanoma	0.00136	0.00358	CcSEcCtD
Isradipine—Angina pectoris—Docetaxel—melanoma	0.00136	0.00358	CcSEcCtD
Isradipine—Ill-defined disorder—Temozolomide—melanoma	0.00136	0.00358	CcSEcCtD
Isradipine—Leukopenia—Carmustine—melanoma	0.00136	0.00357	CcSEcCtD
Isradipine—Anaemia—Temozolomide—melanoma	0.00136	0.00356	CcSEcCtD
Isradipine—Angioedema—Temozolomide—melanoma	0.00134	0.00352	CcSEcCtD
Isradipine—Hypotension—Bleomycin—melanoma	0.00133	0.00348	CcSEcCtD
Isradipine—Oedema—Dactinomycin—melanoma	0.00132	0.00348	CcSEcCtD
Isradipine—Malaise—Temozolomide—melanoma	0.00132	0.00348	CcSEcCtD
Isradipine—Leukopenia—Temozolomide—melanoma	0.00131	0.00345	CcSEcCtD
Isradipine—Palpitations—Temozolomide—melanoma	0.0013	0.00341	CcSEcCtD
Isradipine—Thrombocytopenia—Dactinomycin—melanoma	0.0013	0.00341	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Bleomycin—melanoma	0.00129	0.0034	CcSEcCtD
Isradipine—Chest pain—Carmustine—melanoma	0.00129	0.0034	CcSEcCtD
Isradipine—Anxiety—Carmustine—melanoma	0.00129	0.00338	CcSEcCtD
Isradipine—Cough—Temozolomide—melanoma	0.00128	0.00336	CcSEcCtD
Isradipine—Paraesthesia—Bleomycin—melanoma	0.00127	0.00335	CcSEcCtD
Isradipine—Weight increased—Docetaxel—melanoma	0.00127	0.00335	CcSEcCtD
Isradipine—Dyspnoea—Bleomycin—melanoma	0.00127	0.00332	CcSEcCtD
Isradipine—Arthralgia—Temozolomide—melanoma	0.00125	0.00328	CcSEcCtD
Isradipine—Anxiety—Temozolomide—melanoma	0.00124	0.00327	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00124	0.00326	CcSEcCtD
Isradipine—Oedema—Carmustine—melanoma	0.00124	0.00326	CcSEcCtD
Isradipine—Discomfort—Temozolomide—melanoma	0.00123	0.00324	CcSEcCtD
Isradipine—Decreased appetite—Bleomycin—melanoma	0.00123	0.00324	CcSEcCtD
Isradipine—Acute coronary syndrome—Docetaxel—melanoma	0.00123	0.00323	CcSEcCtD
Isradipine—Myocardial infarction—Docetaxel—melanoma	0.00122	0.00322	CcSEcCtD
Isradipine—Dry mouth—Temozolomide—melanoma	0.00122	0.00321	CcSEcCtD
Isradipine—Thrombocytopenia—Carmustine—melanoma	0.00121	0.00319	CcSEcCtD
Isradipine—Tachycardia—Carmustine—melanoma	0.00121	0.00318	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00121	0.00317	CcSEcCtD
Isradipine—Anaphylactic shock—Temozolomide—melanoma	0.0012	0.00315	CcSEcCtD
Isradipine—Oedema—Temozolomide—melanoma	0.0012	0.00315	CcSEcCtD
Isradipine—Hepatobiliary disease—Docetaxel—melanoma	0.00118	0.0031	CcSEcCtD
Isradipine—Nervous system disorder—Temozolomide—melanoma	0.00117	0.00309	CcSEcCtD
Isradipine—Thrombocytopenia—Temozolomide—melanoma	0.00117	0.00308	CcSEcCtD
Isradipine—Feeling abnormal—Bleomycin—melanoma	0.00117	0.00307	CcSEcCtD
Isradipine—Skin disorder—Temozolomide—melanoma	0.00116	0.00306	CcSEcCtD
Isradipine—Hypotension—Carmustine—melanoma	0.00116	0.00304	CcSEcCtD
Isradipine—Hyperhidrosis—Temozolomide—melanoma	0.00116	0.00304	CcSEcCtD
Isradipine—Decreased appetite—Dactinomycin—melanoma	0.00115	0.00302	CcSEcCtD
Isradipine—Fatigue—Dactinomycin—melanoma	0.00114	0.003	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Carmustine—melanoma	0.00113	0.00297	CcSEcCtD
Isradipine—Urticaria—Bleomycin—melanoma	0.00113	0.00296	CcSEcCtD
Isradipine—Hepatitis—Docetaxel—melanoma	0.00112	0.00294	CcSEcCtD
Isradipine—Insomnia—Carmustine—melanoma	0.00112	0.00294	CcSEcCtD
Isradipine—Hypoaesthesia—Docetaxel—melanoma	0.00111	0.00293	CcSEcCtD
Isradipine—Paraesthesia—Carmustine—melanoma	0.00111	0.00292	CcSEcCtD
Isradipine—Urinary tract disorder—Docetaxel—melanoma	0.00111	0.00291	CcSEcCtD
Isradipine—Dyspnoea—Carmustine—melanoma	0.0011	0.0029	CcSEcCtD
Isradipine—Oedema peripheral—Docetaxel—melanoma	0.0011	0.0029	CcSEcCtD
Isradipine—Somnolence—Carmustine—melanoma	0.0011	0.00289	CcSEcCtD
Isradipine—Connective tissue disorder—Docetaxel—melanoma	0.0011	0.00289	CcSEcCtD
Isradipine—Urethral disorder—Docetaxel—melanoma	0.0011	0.00289	CcSEcCtD
Isradipine—Feeling abnormal—Dactinomycin—melanoma	0.00109	0.00287	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Temozolomide—melanoma	0.00109	0.00287	CcSEcCtD
Isradipine—Insomnia—Temozolomide—melanoma	0.00108	0.00285	CcSEcCtD
Isradipine—Visual impairment—Docetaxel—melanoma	0.00108	0.00284	CcSEcCtD
Isradipine—Decreased appetite—Carmustine—melanoma	0.00108	0.00283	CcSEcCtD
Isradipine—Paraesthesia—Temozolomide—melanoma	0.00107	0.00282	CcSEcCtD
Isradipine—Gastrointestinal disorder—Carmustine—melanoma	0.00107	0.00281	CcSEcCtD
Isradipine—Dyspnoea—Temozolomide—melanoma	0.00107	0.0028	CcSEcCtD
Isradipine—Somnolence—Temozolomide—melanoma	0.00106	0.0028	CcSEcCtD
Isradipine—Constipation—Carmustine—melanoma	0.00106	0.00278	CcSEcCtD
Isradipine—Dyspepsia—Temozolomide—melanoma	0.00105	0.00277	CcSEcCtD
Isradipine—Eye disorder—Docetaxel—melanoma	0.00105	0.00275	CcSEcCtD
Isradipine—Decreased appetite—Temozolomide—melanoma	0.00104	0.00273	CcSEcCtD
Isradipine—Cardiac disorder—Docetaxel—melanoma	0.00104	0.00273	CcSEcCtD
Isradipine—Flushing—Docetaxel—melanoma	0.00104	0.00273	CcSEcCtD
Isradipine—Gastrointestinal disorder—Temozolomide—melanoma	0.00103	0.00272	CcSEcCtD
Isradipine—Fatigue—Temozolomide—melanoma	0.00103	0.00271	CcSEcCtD
Isradipine—Constipation—Temozolomide—melanoma	0.00102	0.00269	CcSEcCtD
Isradipine—Feeling abnormal—Carmustine—melanoma	0.00102	0.00268	CcSEcCtD
Isradipine—Asthenia—Bleomycin—melanoma	0.00102	0.00268	CcSEcCtD
Isradipine—Angiopathy—Docetaxel—melanoma	0.00102	0.00267	CcSEcCtD
Isradipine—Immune system disorder—Docetaxel—melanoma	0.00101	0.00266	CcSEcCtD
Isradipine—Mediastinal disorder—Docetaxel—melanoma	0.00101	0.00265	CcSEcCtD
Isradipine—Pruritus—Bleomycin—melanoma	0.001	0.00264	CcSEcCtD
Isradipine—Feeling abnormal—Temozolomide—melanoma	0.000986	0.00259	CcSEcCtD
Isradipine—Mental disorder—Docetaxel—melanoma	0.000982	0.00258	CcSEcCtD
Isradipine—Malnutrition—Docetaxel—melanoma	0.000975	0.00256	CcSEcCtD
Isradipine—Urticaria—Temozolomide—melanoma	0.000951	0.0025	CcSEcCtD
Isradipine—Asthenia—Dactinomycin—melanoma	0.000949	0.0025	CcSEcCtD
Isradipine—Back pain—Docetaxel—melanoma	0.000943	0.00248	CcSEcCtD
Isradipine—Muscle spasms—Docetaxel—melanoma	0.000938	0.00246	CcSEcCtD
Isradipine—Diarrhoea—Dactinomycin—melanoma	0.000905	0.00238	CcSEcCtD
Isradipine—Vomiting—Bleomycin—melanoma	0.000902	0.00237	CcSEcCtD
Isradipine—Anaemia—Docetaxel—melanoma	0.000901	0.00237	CcSEcCtD
Isradipine—Rash—Bleomycin—melanoma	0.000895	0.00235	CcSEcCtD
Isradipine—Dermatitis—Bleomycin—melanoma	0.000894	0.00235	CcSEcCtD
Isradipine—Asthenia—Carmustine—melanoma	0.000889	0.00234	CcSEcCtD
Isradipine—Syncope—Docetaxel—melanoma	0.000875	0.0023	CcSEcCtD
Isradipine—Leukopenia—Docetaxel—melanoma	0.000873	0.00229	CcSEcCtD
Isradipine—Palpitations—Docetaxel—melanoma	0.000862	0.00227	CcSEcCtD
Isradipine—Asthenia—Temozolomide—melanoma	0.000859	0.00226	CcSEcCtD
Isradipine—Loss of consciousness—Docetaxel—melanoma	0.000857	0.00225	CcSEcCtD
Isradipine—Cough—Docetaxel—melanoma	0.000851	0.00224	CcSEcCtD
Isradipine—Diarrhoea—Carmustine—melanoma	0.000847	0.00223	CcSEcCtD
Isradipine—Pruritus—Temozolomide—melanoma	0.000847	0.00223	CcSEcCtD
Isradipine—Nausea—Bleomycin—melanoma	0.000843	0.00222	CcSEcCtD
Isradipine—Vomiting—Dactinomycin—melanoma	0.000841	0.00221	CcSEcCtD
Isradipine—Rash—Dactinomycin—melanoma	0.000834	0.00219	CcSEcCtD
Isradipine—Arthralgia—Docetaxel—melanoma	0.00083	0.00218	CcSEcCtD
Isradipine—Chest pain—Docetaxel—melanoma	0.00083	0.00218	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000825	0.00217	CcSEcCtD
Isradipine—Dizziness—Carmustine—melanoma	0.000819	0.00215	CcSEcCtD
Isradipine—Diarrhoea—Temozolomide—melanoma	0.000819	0.00215	CcSEcCtD
Isradipine—Dry mouth—Docetaxel—melanoma	0.000812	0.00213	CcSEcCtD
Isradipine—Oedema—Docetaxel—melanoma	0.000796	0.00209	CcSEcCtD
Isradipine—Anaphylactic shock—Docetaxel—melanoma	0.000796	0.00209	CcSEcCtD
Isradipine—Dizziness—Temozolomide—melanoma	0.000792	0.00208	CcSEcCtD
Isradipine—Vomiting—Carmustine—melanoma	0.000788	0.00207	CcSEcCtD
Isradipine—Nausea—Dactinomycin—melanoma	0.000786	0.00207	CcSEcCtD
Isradipine—Shock—Docetaxel—melanoma	0.000783	0.00206	CcSEcCtD
Isradipine—Rash—Carmustine—melanoma	0.000781	0.00205	CcSEcCtD
Isradipine—Nervous system disorder—Docetaxel—melanoma	0.000781	0.00205	CcSEcCtD
Isradipine—Dermatitis—Carmustine—melanoma	0.00078	0.00205	CcSEcCtD
Isradipine—Thrombocytopenia—Docetaxel—melanoma	0.000779	0.00205	CcSEcCtD
Isradipine—Tachycardia—Docetaxel—melanoma	0.000777	0.00204	CcSEcCtD
Isradipine—Headache—Carmustine—melanoma	0.000776	0.00204	CcSEcCtD
Isradipine—Skin disorder—Docetaxel—melanoma	0.000773	0.00203	CcSEcCtD
Isradipine—Vomiting—Temozolomide—melanoma	0.000761	0.002	CcSEcCtD
Isradipine—Rash—Temozolomide—melanoma	0.000755	0.00198	CcSEcCtD
Isradipine—Dermatitis—Temozolomide—melanoma	0.000754	0.00198	CcSEcCtD
Isradipine—Headache—Temozolomide—melanoma	0.00075	0.00197	CcSEcCtD
Isradipine—Hypotension—Docetaxel—melanoma	0.000744	0.00195	CcSEcCtD
Isradipine—Nausea—Carmustine—melanoma	0.000736	0.00193	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000725	0.00191	CcSEcCtD
Isradipine—Insomnia—Docetaxel—melanoma	0.00072	0.00189	CcSEcCtD
Isradipine—Paraesthesia—Docetaxel—melanoma	0.000715	0.00188	CcSEcCtD
Isradipine—Nausea—Temozolomide—melanoma	0.000711	0.00187	CcSEcCtD
Isradipine—Dyspnoea—Docetaxel—melanoma	0.00071	0.00187	CcSEcCtD
Isradipine—Somnolence—Docetaxel—melanoma	0.000708	0.00186	CcSEcCtD
Isradipine—Dyspepsia—Docetaxel—melanoma	0.000701	0.00184	CcSEcCtD
Isradipine—Decreased appetite—Docetaxel—melanoma	0.000692	0.00182	CcSEcCtD
Isradipine—Gastrointestinal disorder—Docetaxel—melanoma	0.000687	0.00181	CcSEcCtD
Isradipine—Fatigue—Docetaxel—melanoma	0.000686	0.0018	CcSEcCtD
Isradipine—Constipation—Docetaxel—melanoma	0.000681	0.00179	CcSEcCtD
Isradipine—Feeling abnormal—Docetaxel—melanoma	0.000656	0.00172	CcSEcCtD
Isradipine—Asthenia—Docetaxel—melanoma	0.000571	0.0015	CcSEcCtD
Isradipine—Pruritus—Docetaxel—melanoma	0.000563	0.00148	CcSEcCtD
Isradipine—Diarrhoea—Docetaxel—melanoma	0.000545	0.00143	CcSEcCtD
Isradipine—Dizziness—Docetaxel—melanoma	0.000526	0.00138	CcSEcCtD
Isradipine—Vomiting—Docetaxel—melanoma	0.000506	0.00133	CcSEcCtD
Isradipine—Rash—Docetaxel—melanoma	0.000502	0.00132	CcSEcCtD
Isradipine—Dermatitis—Docetaxel—melanoma	0.000501	0.00132	CcSEcCtD
Isradipine—Headache—Docetaxel—melanoma	0.000499	0.00131	CcSEcCtD
Isradipine—Nausea—Docetaxel—melanoma	0.000473	0.00124	CcSEcCtD
Isradipine—Nisoldipine—ABCB1—melanoma	0.00039	0.203	CrCbGaD
Isradipine—Nitrendipine—ABCB1—melanoma	0.000364	0.19	CrCbGaD
Isradipine—Amlodipine—ABCB1—melanoma	0.000314	0.164	CrCbGaD
Isradipine—Felodipine—ABCB1—melanoma	0.00029	0.151	CrCbGaD
Isradipine—Nifedipine—ABCB1—melanoma	0.000281	0.146	CrCbGaD
Isradipine—Nicardipine—ABCB1—melanoma	0.000276	0.144	CrCbGaD
Isradipine—CACNA1C—Developmental Biology—RAC1—melanoma	0.000164	0.000462	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—FGF2—melanoma	0.000164	0.000461	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—KRAS—melanoma	0.000163	0.00046	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—CYP1B1—melanoma	0.000163	0.000459	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—VEGFA—melanoma	0.000163	0.000459	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—NOTCH1—melanoma	0.000161	0.000455	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—NRAS—melanoma	0.000161	0.000453	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—PPARG—melanoma	0.000161	0.000453	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—VCAN—melanoma	0.000157	0.000443	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—CTNNB1—melanoma	0.000156	0.000438	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—MMP9—melanoma	0.000155	0.000438	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—MAPK3—melanoma	0.000154	0.000434	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—MMP9—melanoma	0.000152	0.00043	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—PPARG—melanoma	0.000152	0.000429	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—NFKB1—melanoma	0.000151	0.000425	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—ERBB2—melanoma	0.000151	0.000425	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—ERBB2—melanoma	0.000151	0.000425	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—KDR—melanoma	0.00015	0.000424	CbGpPWpGaD
Isradipine—CYP3A4—Tryptophan metabolism—MDM2—melanoma	0.00015	0.000423	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—VCAN—melanoma	0.000149	0.00042	CbGpPWpGaD
Isradipine—CACNB2—Transmission across Chemical Synapses—HRAS—melanoma	0.000148	0.000418	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—MMP2—melanoma	0.000148	0.000416	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—MAP2K1—melanoma	0.000147	0.000416	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—CDK4—melanoma	0.000147	0.000415	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—MET—melanoma	0.000147	0.000415	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—MMP9—melanoma	0.000147	0.000415	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—MAPK1—melanoma	0.000147	0.000413	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—EGFR—melanoma	0.000147	0.000413	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PLA2G6—melanoma	0.000146	0.00041	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—NOTCH1—melanoma	0.000142	0.0004	CbGpPWpGaD
Isradipine—CACNB2—Neuronal System—MAPK1—melanoma	0.000142	0.000399	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—FGF2—melanoma	0.00014	0.000395	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—MMP2—melanoma	0.00014	0.000394	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—VEGFA—melanoma	0.00014	0.000394	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—MAP2K1—melanoma	0.00014	0.000394	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—HRAS—melanoma	0.000139	0.000391	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—KRAS—melanoma	0.000138	0.00039	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—NRAS—melanoma	0.000138	0.000389	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—VEGFA—melanoma	0.000137	0.000386	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—STAT3—melanoma	0.000136	0.000382	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—NRAS—melanoma	0.000135	0.000381	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—ABCB1—melanoma	0.000134	0.000378	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—PPARG—melanoma	0.000134	0.000377	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—FGF2—melanoma	0.000133	0.000374	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—CYP17A1—melanoma	0.000133	0.000374	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—IL6—melanoma	0.000133	0.000374	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—CYP17A1—melanoma	0.000133	0.000374	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—VEGFA—melanoma	0.000132	0.000373	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—MAPK3—melanoma	0.000132	0.000372	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—CTNNB1—melanoma	0.000132	0.000372	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	0.000131	0.000369	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—VCAN—melanoma	0.000131	0.000369	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—NRAS—melanoma	0.000131	0.000368	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—MAPK3—melanoma	0.00013	0.000365	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—MMP9—melanoma	0.000129	0.000365	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—MMP9—melanoma	0.000129	0.000365	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—ERBB2—melanoma	0.000129	0.000365	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—NFKB1—melanoma	0.000128	0.000361	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—MAPK1—melanoma	0.000126	0.000354	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—EGFR—melanoma	0.000126	0.000354	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—CYP17A1—melanoma	0.000126	0.000354	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—GNA11—melanoma	0.000125	0.000353	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—MAPK3—melanoma	0.000125	0.000353	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PRKCA—melanoma	0.000123	0.000348	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—MAPK1—melanoma	0.000123	0.000347	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—EGFR—melanoma	0.000123	0.000347	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—MMP2—melanoma	0.000123	0.000346	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—MAP2K1—melanoma	0.000123	0.000346	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—FASN—melanoma	0.000123	0.000345	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—ERBB2—melanoma	0.000122	0.000345	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—ERCC2—melanoma	0.000122	0.000345	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—SLC5A5—melanoma	0.000121	0.00034	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—MAPK1—melanoma	0.000119	0.000335	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—EGFR—melanoma	0.000119	0.000335	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—KRAS—melanoma	0.000119	0.000335	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—GNA11—melanoma	0.000119	0.000334	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—HRAS—melanoma	0.000118	0.000332	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—TNF—melanoma	0.000117	0.000331	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—FGF2—melanoma	0.000117	0.000329	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—KRAS—melanoma	0.000116	0.000328	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—GNAQ—melanoma	0.000116	0.000328	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—CD44—melanoma	0.000116	0.000328	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—VEGFA—melanoma	0.000116	0.000328	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—VEGFA—melanoma	0.000116	0.000327	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—FASN—melanoma	0.000116	0.000327	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—STAT3—melanoma	0.000115	0.000324	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—NRAS—melanoma	0.000115	0.000324	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—NRAS—melanoma	0.000115	0.000323	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—SLC5A5—melanoma	0.000114	0.000322	CbGpPWpGaD
Isradipine—CACNB2—Neuronal System—HRAS—melanoma	0.000114	0.000321	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—CTNNB1—melanoma	0.000113	0.000319	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—IL6—melanoma	0.000113	0.000317	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—KRAS—melanoma	0.000112	0.000317	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—CYP1B1—melanoma	0.000112	0.000315	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—CYP1B1—melanoma	0.000112	0.000315	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—MMP9—melanoma	0.000111	0.000313	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CYP17A1—melanoma	0.00011	0.000311	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—GNAQ—melanoma	0.00011	0.000311	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—CD44—melanoma	0.00011	0.000311	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	0.00011	0.000311	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—MAPK3—melanoma	0.00011	0.00031	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—MAPK3—melanoma	0.00011	0.00031	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—NFKB1—melanoma	0.00011	0.000309	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—ERBB2—melanoma	0.000108	0.000303	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—CTNNB1—melanoma	0.000107	0.000302	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—CYP1B1—melanoma	0.000106	0.000298	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—MMP9—melanoma	0.000105	0.000296	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—MAPK1—melanoma	0.000105	0.000295	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—EGFR—melanoma	0.000105	0.000295	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—MAPK1—melanoma	0.000105	0.000295	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—EGFR—melanoma	0.000105	0.000295	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—GNA11—melanoma	0.000104	0.000294	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—NFKB1—melanoma	0.000104	0.000293	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—FASN—melanoma	0.000102	0.000287	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—HRAS—melanoma	0.000101	0.000284	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—SLC5A5—melanoma	0.0001	0.000283	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—VEGFA—melanoma	9.96e-05	0.000281	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—TNF—melanoma	9.96e-05	0.000281	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—HRAS—melanoma	9.9e-05	0.000279	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—KRAS—melanoma	9.88e-05	0.000278	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—KRAS—melanoma	9.87e-05	0.000278	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—STAT3—melanoma	9.86e-05	0.000278	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—NRAS—melanoma	9.84e-05	0.000277	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—GNAQ—melanoma	9.69e-05	0.000273	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CD44—melanoma	9.69e-05	0.000273	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PIK3CG—melanoma	9.67e-05	0.000272	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—IL6—melanoma	9.65e-05	0.000272	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—HRAS—melanoma	9.55e-05	0.000269	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—IL6—melanoma	9.47e-05	0.000267	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—VEGFA—melanoma	9.43e-05	0.000266	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—MAPK3—melanoma	9.42e-05	0.000266	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—CTNNB1—melanoma	9.42e-05	0.000265	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—STAT3—melanoma	9.34e-05	0.000263	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PPARG—melanoma	9.33e-05	0.000263	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—NRAS—melanoma	9.32e-05	0.000263	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CYP1B1—melanoma	9.29e-05	0.000262	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—MMP9—melanoma	9.23e-05	0.00026	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—ABCB1—melanoma	9.19e-05	0.000259	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—IL6—melanoma	9.14e-05	0.000258	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—NFKB1—melanoma	9.13e-05	0.000257	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—MAPK1—melanoma	8.97e-05	0.000253	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—EGFR—melanoma	8.96e-05	0.000253	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—MAPK3—melanoma	8.92e-05	0.000252	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—AKT1—melanoma	8.74e-05	0.000246	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—ABCB1—melanoma	8.7e-05	0.000245	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—TNF—melanoma	8.54e-05	0.000241	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PIK3CD—melanoma	8.5e-05	0.00024	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—MAPK1—melanoma	8.49e-05	0.000239	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—EGFR—melanoma	8.49e-05	0.000239	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—KRAS—melanoma	8.47e-05	0.000239	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PRKCA—melanoma	8.46e-05	0.000238	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—HRAS—melanoma	8.4e-05	0.000237	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—HRAS—melanoma	8.39e-05	0.000237	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—ALB—melanoma	8.39e-05	0.000236	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—ERCC2—melanoma	8.39e-05	0.000236	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—VEGFA—melanoma	8.29e-05	0.000234	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—STAT3—melanoma	8.21e-05	0.000231	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—NRAS—melanoma	8.19e-05	0.000231	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—TNF—melanoma	8.09e-05	0.000228	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—IL6—melanoma	8.04e-05	0.000227	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—IL6—melanoma	8.03e-05	0.000226	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—KRAS—melanoma	8.02e-05	0.000226	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PRKCA—melanoma	8.01e-05	0.000226	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—ERCC2—melanoma	7.94e-05	0.000224	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—MAPK3—melanoma	7.84e-05	0.000221	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—ABCB1—melanoma	7.65e-05	0.000216	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—MAPK1—melanoma	7.46e-05	0.00021	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—EGFR—melanoma	7.46e-05	0.00021	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ACER3—melanoma	7.45e-05	0.00021	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—AKT1—melanoma	7.41e-05	0.000209	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PIK3CB—melanoma	7.41e-05	0.000209	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PTGS2—melanoma	7.34e-05	0.000207	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—HRAS—melanoma	7.2e-05	0.000203	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—TNF—melanoma	7.1e-05	0.0002	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—KRAS—melanoma	7.05e-05	0.000199	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PRKCA—melanoma	7.04e-05	0.000198	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—ERCC2—melanoma	6.98e-05	0.000197	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—IL6—melanoma	6.89e-05	0.000194	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—HRAS—melanoma	6.82e-05	0.000192	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—UGT2B10—melanoma	6.81e-05	0.000192	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PIK3CG—melanoma	6.62e-05	0.000187	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—IL6—melanoma	6.52e-05	0.000184	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PTEN—melanoma	6.4e-05	0.00018	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PPARG—melanoma	6.39e-05	0.00018	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—AKT1—melanoma	6.36e-05	0.000179	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—HS3ST5—melanoma	6.33e-05	0.000179	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PIK3CG—melanoma	6.27e-05	0.000177	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PPARG—melanoma	6.06e-05	0.000171	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—AKT1—melanoma	6.02e-05	0.00017	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—HRAS—melanoma	5.99e-05	0.000169	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PIK3CD—melanoma	5.82e-05	0.000164	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—ALB—melanoma	5.75e-05	0.000162	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—IL6—melanoma	5.73e-05	0.000162	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PIK3CD—melanoma	5.52e-05	0.000155	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PIK3CG—melanoma	5.51e-05	0.000155	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—ALB—melanoma	5.44e-05	0.000153	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PPARG—melanoma	5.32e-05	0.00015	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—AKT1—melanoma	5.29e-05	0.000149	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PIK3CB—melanoma	5.08e-05	0.000143	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PTGS2—melanoma	5.03e-05	0.000142	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PIK3CD—melanoma	4.85e-05	0.000137	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PIK3CB—melanoma	4.81e-05	0.000136	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PLCB4—melanoma	4.8e-05	0.000135	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—ALB—melanoma	4.78e-05	0.000135	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PTGS2—melanoma	4.76e-05	0.000134	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PIK3CA—melanoma	4.52e-05	0.000127	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—SLC6A11—melanoma	4.51e-05	0.000127	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PIP4K2A—melanoma	4.51e-05	0.000127	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—MTAP—melanoma	4.39e-05	0.000124	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PTEN—melanoma	4.39e-05	0.000124	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PIK3CB—melanoma	4.22e-05	0.000119	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PTGS2—melanoma	4.19e-05	0.000118	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PTEN—melanoma	4.15e-05	0.000117	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PHGDH—melanoma	3.91e-05	0.00011	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—LUM—melanoma	3.91e-05	0.00011	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—HPSE—melanoma	3.84e-05	0.000108	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CUBN—melanoma	3.77e-05	0.000106	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—AKT1—melanoma	3.69e-05	0.000104	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PTEN—melanoma	3.65e-05	0.000103	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—SDHD—melanoma	3.64e-05	0.000103	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—BSG—melanoma	3.64e-05	0.000103	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CSPG4—melanoma	3.64e-05	0.000103	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GPAM—melanoma	3.52e-05	9.93e-05	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PIK3CA—melanoma	3.09e-05	8.72e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PLA2G6—melanoma	3e-05	8.45e-05	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PIK3CA—melanoma	2.93e-05	8.26e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—VCAN—melanoma	2.69e-05	7.59e-05	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PIK3CA—melanoma	2.57e-05	7.26e-05	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—AKT1—melanoma	2.53e-05	7.13e-05	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—AKT1—melanoma	2.39e-05	6.75e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CYP17A1—melanoma	2.27e-05	6.4e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GNA11—melanoma	2.14e-05	6.04e-05	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—AKT1—melanoma	2.1e-05	5.93e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—FASN—melanoma	2.1e-05	5.92e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—SLC5A5—melanoma	2.06e-05	5.82e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GNAQ—melanoma	1.99e-05	5.62e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CD44—melanoma	1.99e-05	5.62e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CYP1B1—melanoma	1.91e-05	5.39e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ABCB1—melanoma	1.57e-05	4.44e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PRKCA—melanoma	1.45e-05	4.08e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ERCC2—melanoma	1.44e-05	4.05e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PIK3CG—melanoma	1.13e-05	3.2e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PPARG—melanoma	1.09e-05	3.09e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PIK3CD—melanoma	9.97e-06	2.81e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ALB—melanoma	9.84e-06	2.78e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PIK3CB—melanoma	8.69e-06	2.45e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PTGS2—melanoma	8.61e-06	2.43e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PTEN—melanoma	7.51e-06	2.12e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PIK3CA—melanoma	5.3e-06	1.49e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—AKT1—melanoma	4.33e-06	1.22e-05	CbGpPWpGaD
